Oncology Institute Prof. Dr. Ion Chiricuta I.O.C.N.

Cluj-Napoca

1 studies enrolling now · 1 studies all time

What they study most

Multiple Myeloma, Plasma Cell Disorder

Studies at this site

• Study to Assess Safety of HDP-101 in Patients With Relapsed Refractory Multiple Myeloma — Recruiting now